Next 10 |
home / stock / mcujf / mcujf news
WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced today...
2024-04-09 11:01:31 ET More on Medicure Financial information for Medicure Read the full article on Seeking Alpha For further details see: Medicure GAAP EPS of -$0.09, revenue of $21.7M
WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported it...
WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the...
WINNIPEG, MB / ACCESSWIRE / December 5, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, through its pharm...
WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announ...
2023-11-21 17:04:35 ET More on Medicure Financial information for Medicure For further details see: Medicure GAAP EPS of C$0.01, revenue of C$5M
WINNIPEG, MB / ACCESSWIRE / November 21, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today report...
WINNIPEG, MB / ACCESSWIRE / August 29, 2023 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, reaffirms its commi...
2023-07-31 12:44:09 ET Medicure press release ( OTCPK:MCUJF ): Q2 GAAP EPS of C$0.02 vs -C$0.06 in the year ago quarter Revenue of C$6M (+4.3% Y/Y). For further details see: Medicure GAAP EPS of C$0.02, revenue of C$6M
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced today...
WINNIPEG, MB / ACCESSWIRE / April 8, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTCPINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported it...
WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the...